News > Press Releases

Page 17 of 113

Select Year

All | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
FORTH participates in a research program which aims to develop intelligent metasurfaces with programmable electromagnetic behavior, the HyperSurfaces.
Feb 13, 2019
The VISORSURF research project, coordinated by the Foundation for Research and Technology and funded by the EU, aims to produce a first-of-its kind material, the HyperSurface, which can sense electromagnetic waves impinging upon it and alter them in ways dictated by software.
A Νew Εra of laser manufacturing in Europe – Α step closer to reality
Feb 12, 2019
Lasers have become a common feature of everyday life, from laser pointers to laser engraved iPhones and mass-produced laser etched articles in all shapes, sizes and materials. The power of lasers has multiplied many times and they now have sufficient energy to cut and weld thick steel as used in heavy manufacturing.
FORTH and University of Crete win the 1st Hacking Health in Athens!
Feb 12, 2019
The Institute of Computer Science (ICS) of the Foundation for Research and Technology-Hellas (FORTH) and the Medical School of the University of Crete (UOC) participated in the first HACKING HEALTH HACKATHON in Athens and won the first prize, accompanied by 2,000 euros and the opportunity to participate in the Digital Transformation Programme of Roche Diagnostics Hellas.
International scientific collaboration between IMBB Researchers and Scientists at the National Institutes of Health (NIH) of the United States and the University of Oslo, in Norway uncovers the novel role of mitophagy in the pathogenesis of Alzheimer’s disease.
Feb 12, 2019
The findings of the study, published today in the premier international scientific journal Nature Neuroscience, reveal a novel molecular mechanism underlying the beneficial effects of mitophagy, the cellular process of mitochondria recycling, against the pathogenesis of Alzheimer’s disease. IMBB Researchers, Dr. Konstantinos Palikaras and Dr. Nektarios Tavernarakis (Professor at the Medical School, University of Crete, and Chairman of the Board at FORTH) in collaboration with the team of Prof. Vilhem Bohr at the National Institute on Aging (NIA) of the National Institutes of Health, (NIH) in Baltimore, USA, together with Dr. Evandro Fang at the University of Oslo and the Akershus University Hospital, Lørenskog, Norway, demonstrated that mitophagy is impaired in Alzheimer’s disease and that its pharmacological stimulation reverses the disease’s pathological features, including cognitive deficits.